Industry intelligence on the pharmaceutical psilocybin landscape — regulatory developments, manufacturing science, and market dynamics.
A detailed overview of the legal pathway for licensed psilocybin manufacturing in Thailand — from the April 2024 Ministerial Notification to the Form YS-5 narcotics manufacturing license and ONCB export permits.
Comparing the two primary production routes for pharmaceutical-grade psilocybin — natural extraction via CPC purification and total chemical synthesis — across purity, scalability, cost, and regulatory considerations.
An overview of Good Manufacturing Practice requirements specific to psilocybin API production — from facility design and environmental controls to analytical testing, batch documentation, and regulatory audit preparation.
For clinical trial sponsors and CROs, sourcing compliant psilocybin API is one of the most complex procurement challenges in modern drug development. Here's how to navigate it.